CTAC is Canada’s national, non-governmental organization led by and for people living with HIV and viral hepatitis co-infection, focusing on enabling access to treatment. In operation since 1996, CTAC has recently completed an organizational renewal process to ensure we meet our organizational goals to meaningfully engage community members, service providers, policymakers and other relevant stakeholders to identify, develop and implement policy and program solutions.
CTAC understands that treatment access should be considered in its’ holistic form, encompassing the range of treatment, care and support needs required to reach the most successful treatment experience possible for people living with HIV or those co-infected with viral hepatitis.
Treatment Access News
Knowledge Broker, Hepatitis C Community Health Programmingread more
We are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis (PrEP). If you agree, please sign our Open Letter to Gilead Sciences.read more
An innovative approach to disclosure in practice and in consequence. Facilitator’s Workshop Guide.read more
Understanding Approval and Public Listing of Drugs in Canada - The Common Drug Reviewread more
CATIE, CTAC and PositiveLite.com have partnered to lead the development of a Canadian Consensus Statement that it is hoped will be endorsed broadly by healthcare workers, community-based organizations and policy-makers serving the HIV community.read more
AIDS 2014 Community Report Back - Guest Panelists from the CTAC/ICAD/ICASO AIDS 2014 Community Report Back share their thoughts on outcomes from last year's IAS conference in Melbourne, Australia.read more
CTAC Policy Researcher, Barbara Santosuosso, discusses CTAC's new interactive tool, the Treatment Access Map.read more
Shane Patey, CTAC's Executive Director, considers the implications of how we talk about 'risk' when it comes to the burden of HIV/HCV Stigma.read more
Harvoni passed its Common Drug Review this week with the CDEC’s Final Recommendation.
The CDEC’s Final Recommendation advocates that Harvoni be listed for the treatment of chronic hepatitis C virus in adults.read more
Blood Ties Four Directions Centre is seeking to fill the full-time term position (May 2015 to March 2017): Rural Partnership Coordinator.read more
The Positive Justice Project (PJP), a national coalition challenging HIV criminal law policies in the US released a set of principles to guide the modernization of state HIV criminal laws across the country.read more
Cultivating self-care practices can bring meaning and fulfillment to your life.read more
As part of a new priority on co-infections, The International AIDS society has embraced the HIV/Viral Hepatitis Co-Infection meeting as an official satellite symposium to the IAS HIV Pathogenesis conference. This year the meeting will be in Vancouver BC, and is organised by the CIHR Canadian HIV Trials Network.read more
Towards a Canadian Consensus Statement on the Health and Prevention Implications of HIV Treatmentread more
LEARN ABOUT CRIMINALIZATION, DISABILITY INCOME ISSUES, DEALING WITH DEBT PROBLEMS, MEDICAL MARIJUANA LAW AND/OR CITIZENSHIP ISSUES.read more